Shaken, not stirred: Dr Lal PathLabs, Metropolis, et al. feel the heat of aggressive startups
indiatimes.com
news
2022-05-31 19:30:00

Recently, a seven-year-old health-tech player rattled the decades-old diagnostics industry. The disruptor, Tata 1mg, whose revenue is only about a fifth of industry leader Dr Lal PathLabs, launched deep discounts on diagnostics tests to draw customers to its platform. Tata 1mg is offering some routine tests, including lipid profile, liver function, and thyroid profile for just INR100, probably the lowest price in the industry currently. AnotherWhy ?Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectorsStock analysis.
